Trevena Announces Publication of APOLLO-2 Results in Pain Practice
24 juin 2019 07h00 HE
|
Trevena Inc.
CHESTERBROOK, Pa., June 24, 2019 (GLOBE NEWSWIRE) -- Trevena, Inc. (NASDAQ: TRVN), a biopharmaceutical company focused on the development and commercialization of novel medicines for patients with...